Rodin taps Adam Rosenberg for top post

Rodin CEO Adam Rosenberg

Cambridge, MA-based Rodin Therapeutics has recruited biotech vet Adam Rosenberg as its new CEO. Rosenberg plans to stay on as head of Teleos Therapeutics, which is in the business of doing drug discovery work for CNS diseases, until a replacement is found. Rodin is working on an HDAC2 inhibitor for Alzheimer's and other cognitive diseases. Release